Disease | diabetes mellitus, insulin-dependent |
Symptom | C0006111|brain disorders |
Sentences | 1 |
PubMedID- 19837120 | The present study has been designed to establish the potential benefits from 1-methylnicotinamide (mna) treatment on brain disorders associated with type 1 diabetes. |
Page: 1